Skip to content

On this page

Zaltrap

Ziv-Aflibercept

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Zaltrap

Proper name

Ziv-Aflibercept

Licence type

351(a)

BLA number

125418

Applicant

Sanofi-Aventis U.S. LLC

Center

CDER

Presentations

2

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
100MG/4ML (25MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	August 3, 2012
200MG/8ML (25MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	August 3, 2012

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity